Post-Surgical Non-Small Cell Lung Cancer (NSCLC) Follow-up
- Conditions
- Non-Small-Cell Lung Carcinoma
- Registration Number
- NCT00198341
- Lead Sponsor
- Intergroupe Francophone de Cancerologie Thoracique
- Brief Summary
The follow-up of patients operated on for lung cancer is heterogeneous. An intensive follow-up including routine clinic visits, chest X-rays, chest computed tomography (CT) scans and fiberoptic bronchoscopies might detect more small, potentially curable, recurrences and second cancers. However, as it appears in the American Society of Clinical Oncology (ASCO) recommendations, a large randomized study is necessary to evaluate the survival impact of such a follow-up strategy. This is the main objective of this IFCT-0302 study, which is a large randomized controlled study conducted in France comparing this intensive follow-up to a follow-up with only routine clinic visits and chest X-rays.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1775
- completely resected stage I, II, IIIa, and T4 due to satellite tumor nodule(s) N0-2 NSCLC
- stage IIIb to IV NSCLC
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Compare overall survival for each arm 6-month
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (7)
Centre Hospitalier - Pneumologie
🇫🇷Belfort, France
CHU Besancon - Pneumologie
🇫🇷Besancon, France
Centre F. Baclesse
🇫🇷Caen, France
CHU - Pneumologie
🇫🇷Caen, France
CHU Grenoble - pneumologie
🇫🇷Grenoble, France
Institut de Cancérologie de la Loire
🇫🇷Saint-priest En Jarez, France
CHU Lyautey - Pneumologie
🇫🇷Strasbourg, France
Centre Hospitalier - Pneumologie🇫🇷Belfort, France